Caroline Dorsa
Board Member
Illumina, Inc. (ILMN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Caroline Dorsa
Caroline Dorsa is recorded as Board Member at Illumina, Inc. (ILMN). Intellia Therapeutics, Inc. reported in an 8-K filed April 17, 2023 that Caroline Dorsa retired as director (audit committee chair), effective June 15, 2023.
“Ms. Dorsa is retiring from Intellia's board, effective June 15, 2023, as a result of her appointment as chair of Biogen's board of directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-05-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Illumina, Inc.
Other people whose current roles at this company are on record from its filings.
- Jay T. Flatley Chairman
- John W. Thompson Chairman
- Scott Gottlieb Chairman, Board Member
- Stephen P. MacMillan Chairman, Board Member
- Ankur Dhingra CFO
- Steve Barnard CTO
- Steven Barnard CTO
- Charles Dadswell General Counsel
- Scott Davies General Counsel
- Scott Ericksen Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.